TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15598679

Group type: EXPERIMENTAL
Intervention: AA/CHO supplement
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 13
Study: 12753445

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine 0.5 ml.kg‐1
Number of subjects: 2

Group type: COMPARATOR
Intervention: 0.25% bupivacaine 0.5 ml.kg‐1 with 1 microg x kg‐1 neostigmine
Number of subjects: 2
Study: 9930771

Group type: EXPERIMENTAL
Intervention: Simulation training with lecture and videotape review
Number of subjects: 24
Study: 7569819

Group type: EXPERIMENTAL
Intervention: Pulsed ultrasound treatment
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo ultrasound treatment
Number of subjects: 72
Study: 2142589

Group type: EXPERIMENTAL
Intervention: Enoximone (group E, n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dobutamine (group D, n = 10)
Number of subjects: 20
Study: 7389058

Group type: EXPERIMENTAL
Intervention: Low-dose cyclophosphamide (CTX) 100 mg/day continuously
Number of subjects: 74

Group type: COMPARATOR
Intervention: Adriamycin (ADM) 50 mg/m2 IV every 4 weeks plus CTX 100 mg/day
Number of subjects: 74
Study: 31272912

Group type: EXPERIMENTAL
Intervention: Self-harm surveillance system
Number of subjects: 2259
Study: 27457790

Group type: EXPERIMENTAL
Intervention: Polysaccharide-resin-honey based cough syrup
Number of subjects: 150

Group type: COMPARATOR
Intervention: Carbocysteine syrup
Number of subjects: 150
Study: 25412569

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIg)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo (albumin)
Number of subjects: 82
Study: 23797047

Group type: EXPERIMENTAL
Intervention: SCE teaching with dermoscopy tutorial and a dermatoscope (Cohort 2)
Number of subjects: 288

Group type: COMPARATOR
Intervention: SCE teaching only (Cohort 1)
Number of subjects: 288
Study: 21755833

Group type: EXPERIMENTAL
Intervention: ROTEM analysis (EXTEM_CFT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ROTEM analysis (INTEM_CFT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ROTEM analysis (PLT/INTEM)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ROTEM analysis (FIB/MCF_FIBTEM)
Number of subjects: 30
Study: 19933083

Group type: EXPERIMENTAL
Intervention: IMC-1121B (ramucirumab) plus docetaxel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus docetaxel
Number of subjects: 0
Study: 16478844

Group type: EXPERIMENTAL
Intervention: Interdisciplinary intervention group receiving medical care, asthma education, and problem-solving therapy (n = 89)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Comparison group receiving medical care alone (n = 86)
Number of subjects: 175
Study: 12776011

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy
Number of subjects: 0
Study: 11096044

Group type: EXPERIMENTAL
Intervention: Combined conventional treatment and sorbent suspension dialysis (6-hour treatment)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Conventional treatment only
Number of subjects: 41
Study: 9375591

Group type: EXPERIMENTAL
Intervention: Clomipramine treatment starting at 10 mg/day, gradually increased to a mean dose of 97 mg/day
Number of subjects: 58
Study: 8262686

Group type: EXPERIMENTAL
Intervention: Pirenzepine and H2-receptor antagonists (cimetidine, ranitidine)
Number of subjects: 21
Study: 2993147

Group type: EXPERIMENTAL
Intervention: Sclerotherapy
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control
Number of subjects: 116
Study: 28946540

Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional Rehabilitation (CR)
Number of subjects: 45
Study: 25730597

Group type: EXPERIMENTAL
Intervention: Radiation therapy
Number of subjects: 84
Study: 26417001

Group type: EXPERIMENTAL
Intervention: Adjuvant hormone therapy (AHT) for 5 years
Number of subjects: 150

Group type: COMPARATOR
Intervention: No AHT (control)
Number of subjects: 150
Study: 23518209

Group type: EXPERIMENTAL
Intervention: Partial reduction orthokeratology (PR ortho-k)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Spectacle-wearing control
Number of subjects: 52
Study: 21609167

Group type: EXPERIMENTAL
Intervention: Mixed program of laboratory trainings and practice in PHC centers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Skills laboratory training
Number of subjects: 0
Study: 19785251

Group type: EXPERIMENTAL
Intervention: Explicit problem-solving skills training program using a metacomponential approach
Number of subjects: 33

Group type: COMPARATOR
Intervention: Conventional cognitive training approach (control)
Number of subjects: 33
Study: 16674618

Group type: EXPERIMENTAL
Intervention: Fibreoptic bronchoscope
Number of subjects: 100

Group type: COMPARATOR
Intervention: Direct laryngoscopy
Number of subjects: 100
Study: 15080818

Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 246

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 246
Study: 11264141

Group type: EXPERIMENTAL
Intervention: Proxymetacaine-fluorescein (PROX-FLU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lignocaine-fluorescein (LIG-FLU)
Number of subjects: 0
Study: 9278212

Group type: EXPERIMENTAL
Intervention: Theophylline (non-specific adenosine antagonist)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dipyridamole (adenosine reuptake inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8020521

Group type: EXPERIMENTAL
Intervention: iomeprol 200 mgI/ml
Number of subjects: 100

Group type: COMPARATOR
Intervention: iopamidol 200 mgI/ml
Number of subjects: 100
Study: 2532444

Group type: EXPERIMENTAL
Intervention: Droperidol 0.010 mg/kg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Droperidol 0.005 mg/kg
Number of subjects: 32
Study: 810268

Group type: EXPERIMENTAL
Intervention: Intranasal betamethasone valerate
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sodium cromoglycate
Number of subjects: 40
Study: 31724354

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 104

Group type: COMPARATOR
Intervention: Western medication (conjugated estrogens and medroxyprogesterone acetate)
Number of subjects: 104
Study: 28323173

Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT) + Optimal Pharmacological Therapy (OPT)
Number of subjects: 293

Group type: COMPARATOR
Intervention: Optimal Pharmacological Therapy (OPT)
Number of subjects: 293
Study: 25288560

Group type: EXPERIMENTAL
Intervention: Intervention group (dog walking strategy)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 49
Study: 25049048

Group type: EXPERIMENTAL
Intervention: Dietary medium chain fatty acids (MCFA) supplementation (60 grams/day, mainly C8:0, C10:0)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Linoleic acid supplementation
Number of subjects: 12
Study: 22731889

Group type: EXPERIMENTAL
Intervention: Active attention training program (directing attention away from threat)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo attention training program (probe appeared with equal frequency in threatening and neutral faces)
Number of subjects: 79
Study: 21029815

Group type: EXPERIMENTAL
Intervention: Peak cardiac troponin-T (TnT)
Number of subjects: 1237

Group type: EXPERIMENTAL
Intervention: Creatine kinase-MB (CK-MB)
Number of subjects: 1237

Group type: EXPERIMENTAL
Intervention: Final infarct size on SPECT scan
Number of subjects: 1237
Study: 18790668

Group type: EXPERIMENTAL
Intervention: Home TV-channel providing educational materials (Intervention group)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Standard follow-up by cardiologists and HF-nurses (Control group)
Number of subjects: 214
Study: 16195255

Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 144

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 144
Study: 12594415

Group type: EXPERIMENTAL
Intervention: Modified bionator
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination headgear
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed treatment until permanent dentition
Number of subjects: 0
Study: 10376260

Group type: EXPERIMENTAL
Intervention: 0.2 mg/cc MMC
Number of subjects: 50

Group type: COMPARATOR
Intervention: 0.4 mg/cc MMC
Number of subjects: 50
Study: 9066364

Group type: EXPERIMENTAL
Intervention: Desferrioxamine (iron chelator) for 10 months
Number of subjects: 1
Study: 8101903

Group type: EXPERIMENTAL
Intervention: Acridine orange leucocyte cytospin (AOLC) test
Number of subjects: 0

Group type: COMPARATOR
Intervention: C-reactive protein test
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nitroblue tetrazolium test
Number of subjects: 0
Study: 3460737

Group type: EXPERIMENTAL
Intervention: Ofloxacin (300 mg) with breakfast
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ofloxacin (300 mg) fasting
Number of subjects: 12
Study: 29511018

Group type: COMPARATOR
Intervention: Provisional stenting (PS)
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Two-stent technique
Number of subjects: 660
Study: 27651908

Group type: EXPERIMENTAL
Intervention: Pulmonary artery perfusion with oxygenated blood (n=30)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Pulmonary artery perfusion with histidine‐tryptophan‐ketoglutarate (HTK) solution (n=29)
Number of subjects: 90

Group type: COMPARATOR
Intervention: No pulmonary perfusion (n=31)
Number of subjects: 90
Study: 25915979

Group type: EXPERIMENTAL
Intervention: Sporting Compression (SC) tights
Number of subjects: 19
Study: 22418699

Group type: EXPERIMENTAL
Intervention: Anastrozole plus gefitinib
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Fulvestrant plus gefitinib
Number of subjects: 141
Study: 20390292

Group type: EXPERIMENTAL
Intervention: Experimental group (n = 9) - unilateral plantar-flexor muscles fatigue
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (n = 9) - standing rest period
Number of subjects: 18
Study: 18194595

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg once daily
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190
Study: 15933485

Group type: EXPERIMENTAL
Intervention: Venlafaxine XR (n = 560)
Number of subjects: 1391

Group type: COMPARATOR
Intervention: Fluoxetine/Paroxetine (n = 298)
Number of subjects: 1391

Group type: COMPARATOR
Intervention: Placebo (n = 496)
Number of subjects: 1391
Study: 12848396

Group type: EXPERIMENTAL
Intervention: Health technology assessment (HTA) initiatives
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 10321525

Group type: EXPERIMENTAL
Intervention: Topical diclofenac
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Topical dexamethasone
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (BSS)
Number of subjects: 60
Study: 8932119

Group type: EXPERIMENTAL
Intervention: Dry Powder Device (DPD)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Metered Dose Inhaler (MDI)
Number of subjects: 27
Study: 8333805

Group type: COMPARATOR
Intervention: Blacks
Number of subjects: 704

Group type: COMPARATOR
Intervention: Whites
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 704
Study: 3108794

Group type: EXPERIMENTAL
Intervention: 1 day of perioperative prophylaxis with cefoperazone sodium
Number of subjects: 109

Group type: COMPARATOR
Intervention: 5 days of perioperative antibiotic prophylaxis with cefoperazone sodium
Number of subjects: 109
Study: 30056616

Group type: EXPERIMENTAL
Intervention: Culturally adapted/rural kiR curriculum
Number of subjects: 2781

Group type: EXPERIMENTAL
Intervention: Non-adapted/urban kiR curriculum (high delivery quality)
Number of subjects: 2781

Group type: COMPARATOR
Intervention: Non-adapted/urban kiR curriculum (low delivery quality)
Number of subjects: 2781

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 2781
Study: 27225652

Group type: EXPERIMENTAL
Intervention: Internet-based self-help intervention (Take Care of You - TCOY)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparable intervention focusing on problematic alcohol use only
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 0
Study: 24688181

Group type: EXPERIMENTAL
Intervention: Rules of Two (Ro2)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Asthma Control Test (ACT)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Self-assessment by patients
Number of subjects: 150

Group type: COMPARATOR
Intervention: Evaluation of static lung function
Number of subjects: 150
Study: 22057307

Group type: EXPERIMENTAL
Intervention: 21-lesson classroom-based intervention (The Fourth R)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 196
Study: 20657857

Group type: EXPERIMENTAL
Intervention: Audiovisual distraction (AVD) with video eyeglasses
Number of subjects: 120

Group type: COMPARATOR
Intervention: Nitrous oxide sedation
Number of subjects: 120
Study: 18245800

Group type: EXPERIMENTAL
Intervention: Various experimental treatments (specific treatments not detailed)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Not applicable (general quality indicators assessed)
Number of subjects: 52
Study: 15880062

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 1052
Study: 12578788

Group type: COMPARATOR
Intervention: TTT alone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TTT + ICG
Number of subjects: 60
Study: 10100144

Group type: EXPERIMENTAL
Intervention: Vinorelbine 25 mg/m2 on days 1 and 8; Gemcitabine 1000 mg/m2 on days 1 and 8; Cisplatin 75 mg/m2 on day 8, repeated every 21 days for a maximum of six cycles.
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Vinorelbine, gemcitabine, and cisplatin combination therapy
Number of subjects: 31
Study: 8915032

Group type: EXPERIMENTAL
Intervention: Linomide (8-9 mg/kg/day) in drinking water
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Linomide (10 mg/kg) i.p. for 3 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Linomide (8-9 mg/kg/day) with rhIL-1beta (4.0 microg/kg) i.p. daily for 5 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: rhIL-1beta (4.0 microg/kg) i.p. daily for 5 days
Number of subjects: 0
Study: 1745715

Group type: EXPERIMENTAL
Intervention: Lorazepam (0.0, 0.6, 0.13, 0.25, and 0.5 mg; total cumulative dose: 0.94 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Lorazepam (0.94 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 9
Study: 6815252

Group type: EXPERIMENTAL
Intervention: 250 micrograms of aerosolized terbutaline
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 500 micrograms of aerosolized terbutaline q.i.d.
Number of subjects: 13
Study: 30060087

Group type: EXPERIMENTAL
Intervention: Infrared coagulation (IRC) ablation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Active monitoring (AM)
Number of subjects: 120
Study: 28273202

Group type: EXPERIMENTAL
Intervention: Interdisciplinary psychoeducation-based intervention
Number of subjects: 183

Group type: COMPARATOR
Intervention: Traditional intervention
Number of subjects: 183
Study: 26090758

Group type: EXPERIMENTAL
Intervention: Lidocaine 5% patch
Number of subjects: 46
Study: 24669858

Group type: EXPERIMENTAL
Intervention: Directional compression shorts (CoreShort PRO, Under Armour, USA)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Non-directional compression shorts (HeatGear, Under Armour, USA)
Number of subjects: 29
Study: 22221461

Group type: EXPERIMENTAL
Intervention: Researcher-designed word-problem intervention
Number of subjects: 31

Group type: COMPARATOR
Intervention: Researcher-designed calculation intervention
Number of subjects: 31

Group type: COMPARATOR
Intervention: Business-as-usual (teacher-designed) control
Number of subjects: 31
Study: 18614145

Group type: EXPERIMENTAL
Intervention: Spaced education e‐mails on prostate cancer (PC) and prostate‐specific antigen (PSA) screening
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Spaced education e‐mails on benign prostatic hyperplasia (BPH) and erectile dysfunction (ED)
Number of subjects: 115
Study: 17490769

Group type: EXPERIMENTAL
Intervention: Radiotherapy for benign disorders (specific details not provided)
Number of subjects: 0
Study: 15612833

Group type: EXPERIMENTAL
Intervention: Raloxifene treatment
Number of subjects: 0
Study: 11386605

Group type: EXPERIMENTAL
Intervention: Fasting venous plasma glucose (FPG) measurement in low-risk population (n=424)
Number of subjects: 726

Group type: COMPARATOR
Intervention: Comparison with WHO and ADA recommendations
Number of subjects: 726

Group type: EXPERIMENTAL
Intervention: Subclassification of reference population
Number of subjects: 726
Study: 9678282

Group type: COMPARATOR
Intervention: Probucol (500 mg/day)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Cilostazol (200 mg/day)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Probucol plus cilostazol
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control
Number of subjects: 126
Study: 8067708

Group type: EXPERIMENTAL
Intervention: CFA (Colony Forming Assay)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: MTT-test
Number of subjects: 70

Group type: COMPARATOR
Intervention: ACNU or BCNU (adjuvant chemotherapy)
Number of subjects: 70
Study: 3058088

Group type: EXPERIMENTAL
Intervention: Methylphenidate withdrawal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methylphenidate withdrawal for two summers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methylphenidate treatment
Number of subjects: 0
Study: 30423419

Group type: EXPERIMENTAL
Intervention: Current alcohol use disorder
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: Antisocial personality disorder
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: Higher rates of current manic episode
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: Higher current illness severity (CGI score)
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: Bipolar disorder diagnosis
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: Younger age
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: Antidepressant consumption
Number of subjects: 675
Study: 28270194

Group type: EXPERIMENTAL
Intervention: Alcohol Brief Intervention (ABI), a 20 min motivational counselling interview
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Alcohol Brief Intervention (ABI)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Hospital admission
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Presence of a 'significant other'
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Purpose or structure with activities linked to employment/social/leisure pursuits
Number of subjects: 10
Study: 26322544

Group type: EXPERIMENTAL
Intervention: Live Lactobacillus rhamnosus GG
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Heat-inactivated Lactobacillus rhamnosus GG
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control juice
Number of subjects: 59
Study: 23611212

Group type: EXPERIMENTAL
Intervention: Dasatinib 100 mg orally daily
Number of subjects: 37

Group type: COMPARATOR
Intervention: Imatinib 400 mg orally daily
Number of subjects: 37
Study: 20800376

Group type: EXPERIMENTAL
Intervention: Total body irradiation (TBI) with 800 cGy delivered in two 200‐cGy fractions twice a day before CD34(+) selected autologous hematopoietic stem cell transplantation.
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Kidney shielding techniques using ultrasound (US) and noncontrast computerized tomography (CT) or CT imaging alone.
Number of subjects: 11
Study: 18753213

Group type: EXPERIMENTAL
Intervention: Echocardiography and IEGM methods for VV delay optimization during exercise
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Echocardiography and IEGM methods for AV delay optimization during exercise
Number of subjects: 24
Study: 17146008

Group type: EXPERIMENTAL
Intervention: C‐ECT (10 treatments)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: C‐Pharm (lithium carbonate plus nortriptyline hydrochloride for 6 months)
Number of subjects: 201

Group type: COMPARATOR
Intervention: C‐ECT
Number of subjects: 201

Group type: COMPARATOR
Intervention: C‐Pharm
Number of subjects: 201
Study: 14762617

Group type: EXPERIMENTAL
Intervention: Guidelines for epilepsy treatment based on the opinion of Brazilian experts
Number of subjects: 0

Group type: COMPARATOR
Intervention: North-American guidelines
Number of subjects: 0
Study: 10750067

Group type: EXPERIMENTAL
Intervention: Daily iron/folate supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iron/folate supplementation with added vitamin C
Number of subjects: 0

Group type: COMPARATOR
Intervention: Once-weekly iron/folate supplementation
Number of subjects: 0
Study: 8956375

Group type: EXPERIMENTAL
Intervention: Oxazepam (30 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lorazepam (2 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 1549934

Group type: EXPERIMENTAL
Intervention: Gradual increase of isoflurane concentration from 0.5% to 3%
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sudden increase of isoflurane concentration from 0.5% to 3%
Number of subjects: 20
Study: 3545900

Group type: EXPERIMENTAL
Intervention: Rengasil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Piroxicam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31274545

Group type: EXPERIMENTAL
Intervention: TAP block with 20ml of ropivacaine 0.375% + 75μg of clonidine
Number of subjects: 182

Group type: COMPARATOR
Intervention: Intrathecal morphine (ITM) with 100μg of morphine
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: TAP block
Number of subjects: 182

Group type: COMPARATOR
Intervention: Intrathecal morphine (ITM)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 182
Study: 29386253

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) in the caudal zona incerta (cZi)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Best medical treatment
Number of subjects: 25
Study: 26899568

Group type: EXPERIMENTAL
Intervention: High roasted coffee (HRC)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low roasted coffee (LRC)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Unroasted coffee (URC)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: In vitro hydrolyzed unroasted coffee (HURC)
Number of subjects: 12
Study: 24656784

Group type: EXPERIMENTAL
Intervention: Ward-led intervention to increase hand hygiene behavior
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Barriers to implementation
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Facilitators of implementation
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Recommendations for improvement
Number of subjects: 17
Study: 23153344

Group type: EXPERIMENTAL
Intervention: Resistance training (60% of 1-Repetition Maximum, for 12 weeks)
Number of subjects: 45